Association which comprises 4 - {3 - [CIS hexahydrocyclopenta [c] pyrrole - 2 (1H) - yl] benzamide propoxy} and an antagonist of NMDA Receptors, Pharmaceutical Composition and use for the treatment of cognitive disorders associated with Brain Aging and Neurodegenerative Diseases such as Alzheimer's disease.

• 收藏
• 分享

专利权人:

LES LABORATOIRES SERVIER

发明人:

AURORE SORS,CARYN TROCME-THIBIERGE,ANNETTE MERDES

申请号：

CL2012003437

公开号：

CL2012003437A1

申请日:

2012.12.06

申请国别(地区):

CL

年份:

2014

代理人:

摘要：

Combination comprises 4-{3-[cis-hexahydrocyclopenta[c]pyrrol-2(1H)-yl]propoxy}benzamide (I) or its addition salt with an acid or a base, and N-methyl-D-aspartate glutamate receptor antagonist. ACTIVITY : Nootropic. MECHANISM OF ACTION : N-methyl-D-aspartate glutamate receptor antagonist.ASOCIACION QUE COMPRENDE 4-{3-[CIS-HEXAHIDROCICLOPENTA[C]PIRROL-2(1H)-IL]PROPOXI}BENZAMIDA O UNA DE SUS SALES Y UN ANTAGONISTA DE LOS RECEPTORES GLUTAMATERGICOS NMDA； COMPOSICION FARMACEUTICA； USO PARA TRATAR TRASTORNOS COGNITIVOS ASOCIADOS AL ENVEJECIMIENTO Y A LAS ENFERMEDADES NEURODEGENERATIVAS.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/